Published in Eur J Pharmacol on June 02, 2000
Hydrogen sulphide and angiogenesis: mechanisms and applications. Br J Pharmacol (2011) 1.63
EDHF: spreading the influence of the endothelium. Br J Pharmacol (2011) 1.54
Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. Br J Pharmacol (2003) 1.37
Spreading dilatation in rat mesenteric arteries associated with calcium-independent endothelial cell hyperpolarization. J Physiol (2004) 1.31
Bradykinin-induced, endothelium-dependent responses in porcine coronary arteries: involvement of potassium channel activation and epoxyeicosatrienoic acids. Br J Pharmacol (2005) 1.28
Suppression of K(+)-induced hyperpolarization by phenylephrine in rat mesenteric artery: relevance to studies of endothelium-derived hyperpolarizing factor. Br J Pharmacol (2001) 1.17
Thromboxane receptor stimulation associated with loss of SKCa activity and reduced EDHF responses in the rat isolated mesenteric artery. Br J Pharmacol (2004) 1.00
Multiplicity of effectors of the cardioprotective agent, diazoxide. Pharmacol Ther (2013) 0.95
Smooth muscle Ca(2+) -activated and voltage-gated K+ channels modulate conducted dilation in rat isolated small mesenteric arteries. Microcirculation (2011) 0.85
Smooth muscle membrane potential modulates endothelium-dependent relaxation of rat basilar artery via myo-endothelial gap junctions. J Physiol (2002) 0.84
Na+-K+-ATPase is involved in the sustained ACh-induced hyperpolarization of endothelial cells from rat aorta. Br J Pharmacol (2006) 0.83
KATP Channels in the Cardiovascular System. Physiol Rev (2016) 0.82
β₁-Adrenoceptor stimulation suppresses endothelial IK(Ca)-channel hyperpolarization and associated dilatation in resistance arteries. Br J Pharmacol (2013) 0.77
Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism. Nature (1974) 2.97
A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br J Pharmacol (1997) 1.94
The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. Br J Pharmacol (1998) 1.68
Neocortical cholinergic neurons in elderly people. Lancet (1977) 1.68
The binding of (3H)-propylbenzilycholine mustard by longitudinal muscle strips from guinea-pig small intestine. Br J Pharmacol (1974) 1.62
Binding of agonists and antagonists to muscarinic receptors. J Supramol Struct (1976) 1.50
Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br J Pharmacol (1997) 1.38
Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol (2000) 1.38
Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br J Pharmacol (2001) 1.35
The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery. Br J Pharmacol (1998) 1.34
Autoradiographic visualization of the binding sites for [125I]endothelin in rat and human brain. Neurosci Lett (1989) 1.33
Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the rat. Br J Pharmacol (1989) 1.33
The properties of muscarinic receptors in mammalian cerebral cortex. Br J Pharmacol (1974) 1.20
Detergent and methylene blue affect endothelium-dependent vasorelaxation and pressure/flow relations in rat blood perfused mesenteric arterial bed. Br J Pharmacol (1988) 1.12
Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat. Br J Pharmacol (1990) 1.10
Effects of alpha-adrenoceptor agonists on cardiac output and its regional distribution in the pithed rat. Br J Pharmacol (1987) 1.01
Identification of adrenoceptors and dopamine receptors mediating vascular responses in the superior mesenteric arterial bed of the rat. J Pharm Pharmacol (1985) 0.97
Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16-21) and other endothelin-related peptides in the rat. Br J Pharmacol (1991) 0.95
Labelling of cholinergic receptors in subcellular fractions from rat cerebral cortex. Biochem J (1972) 0.95
Endothelium-dependent modulation of the pressor activity of arginine vasopressin in the isolated superior mesenteric arterial bed of the rat. Br J Pharmacol (1988) 0.94
Effect of phenobarbitone pretreatment upon endothelium-dependent relaxation to acetylcholine in rat superior mesenteric arterial bed. Br J Pharmacol (1988) 0.92
Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers. Lab Invest (1995) 0.91
Autoradiographic localisation of endothelin binding sites in kidney. Eur J Pharmacol (1989) 0.91
Characteristics of endothelin-1 and endothelin-3 stimulation of phosphoinositide breakdown differ between regions of guinea-pig and rat brain. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.90
Effects of moderate hypoxia, hypercapnia and acidosis on haemodynamic changes induced by endothelin-1 in the pithed rat. Br J Pharmacol (1989) 0.90
Effects of enalapril on changes in cardiac output and organ vascular resistances induced by alpha 1- and alpha 2-adrenoceptor agonists in pithed normotensive rats. Br J Pharmacol (1988) 0.89
Endothelium and cannabinoid receptor involvement in levcromakalim vasorelaxation. Eur J Pharmacol (1997) 0.89
Effect of artificial respiratory volume on the cardiovascular responses to an alpha 1- and an alpha 2-adrenoceptor agonist in the air-ventilated pithed rat. Br J Pharmacol (1988) 0.89
Effects of chemical sympathectomy with 6-hydroxydopamine on cardiac output and its distribution in the rat. Eur J Pharmacol (1985) 0.89
Modulation of relaxation to levcromakalim by S-nitroso-N-acetylpenicillamine (SNAP) and 8-bromo cyclic GMP in the rat isolated mesenteric artery. Br J Pharmacol (1998) 0.89
The distribution of muscarinic receptor sites in the nervous system of the dog. J Neurochem (1974) 0.89
Effects of phenobarbitone and 6-methylprednisolone pretreatment on pressure/flow relations in the superior mesenteric and iliac arterial beds of the rat. J Pharm Pharmacol (1985) 0.88
Endothelial modulation and changes in endothelin pressor activity during hypoxia in the rat isolated perfused superior mesenteric arterial bed. Br J Pharmacol (1991) 0.88
Proceedings: Two populations of acetylcholine receptors in guinea-pig ileum. Br J Pharmacol (1974) 0.88
Protein kinase A-dependent and -independent effects of isoproterenol in rat isolated mesenteric artery: interactions with levcromakalim. J Pharmacol Exp Ther (2001) 0.87
Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model. Br J Pharmacol (1996) 0.87
Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts. Br J Pharmacol (2001) 0.86
Autoradiographic visualization and characteristics of [125I]bradykinin binding sites in guinea pig brain. Brain Res (1992) 0.86
Quantification of the repair process involved in the repair of a cell monolayer using an in vitro model of mechanical injury. Angiogenesis (1998) 0.85
Differential effects of hepatic microsomal enzyme inducing agents on liver blood flow. Biochem Pharmacol (1978) 0.84
Functional studies on endothelin catch up with molecular biology. Trends Pharmacol Sci (1989) 0.84
Alterations in liver blood flow during glycerol-induced acute renal failure in the rat. Nephron (1980) 0.84
Identification of beta-adrenoceptors and histamine receptors in the cat nasal vasculature. Acta Otolaryngol (1978) 0.84
Effect of neuropeptide Y on cardiac output, its distribution, regional blood flow and organ vascular resistances in the pithed rat. Br J Pharmacol (1990) 0.83
Endothelin-3 mediated proliferation in wounded human umbilical vein endothelial cells. Biochem Biophys Res Commun (1993) 0.83
Effect of destruction of the vascular endothelium upon pressure/flow relations and endothelium-dependent vasodilatation in resistance beds of spontaneously hypertensive rats. Clin Sci (Lond) (1991) 0.81
Effects of K+ channel openers on relaxations to nitric oxide and endothelium-derived hyperpolarizing factor in rat mesenteric artery. Eur J Pharmacol (1998) 0.80
Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat. Br J Pharmacol (2007) 0.79
Pressor effects of the alpha 2-adrenoceptor agonist B-HT 933 in anaesthetized and haemorrhagic rats: comparison with the haemodynamic effects of amidephrine. Br J Pharmacol (1989) 0.78
The effect of age on cardiac output and its distribution in the rat. Experientia (1979) 0.78
Interactions between noradrenaline and alpha 2-adrenoceptor agonists in the superior mesenteric arterial bed of the rat. Br J Pharmacol (1986) 0.78
Endothelin receptor heterogeneity; structure activity, autoradiographic and functional studies. J Recept Res (1991) 0.77
Phenobarbitone effects on hepatic microsomal enzymes and liver blood flow in the guinea pig. Biochem Pharmacol (1979) 0.77
Effect of the blood substitute diaspirin crosslinked hemoglobin in rat mesenteric and human radial collateral arteries. J Cardiovasc Pharmacol (2001) 0.77
High-affinity bradykinin B2 binding sites sensitive to guanine nucleotides in bovine aortic endothelial cells. Eur J Pharmacol (1991) 0.77
Distribution of cardiac output in different models of hypertension in the conscious rat. Pflugers Arch (1979) 0.77
Interaction of cyclic AMP modulating agents with levcromakalim in the relaxation of rat isolated mesenteric artery. Eur J Pharmacol (2000) 0.77
Short term reductions in cerebral muscarinic receptor concentration of the mouse after in vivo administration of cycloheximide. Biochem Pharmacol (1984) 0.77
Characterization of calcium signals provoked by lysophosphatidylinositol in human microvascular endothelial cells. Physiol Res (2015) 0.76
The effect of rifampicin on liver blood flow, microsomal enzyme activity and bile flow in the rat. Biochem Pharmacol (1979) 0.76
Anti-dopaminergic and anti-muscarinic effects of dibenzodiazepines: relationship to drug induced Parkinsonism. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.75
Comparison of the effects of the hypolipidaemic agents ICI53072 and clofibrate with those of phenobarbitone on liver size, blood flow and DNA content in the rat. Br J Pharmacol (1983) 0.75
Decreased muscarinic receptor concentration in post-mortem brain in Huntington's chorea. Brain Res (1974) 0.75
The effects of four general anaesthetic agents on the regional distribution of cardiac output in the rat [proceedings]. Br J Pharmacol (1977) 0.75
Ontogenesis of muscarinic receptor sites in rat brain [proceedings]. Br J Pharmacol (1976) 0.75
Extended mepyramine treatment and histamine H1-receptors in guinea-pig brain. Eur J Pharmacol (1981) 0.75
Effects of phenobarbitone on hepatic microsomal enzyme activity and liver blood flow in spontaneously hypertensive rats. Life Sci (1979) 0.75
Comparison of the effects of intravenous and intrasplenic infusions of glucagon on cardiac output and its distribution in the rat. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.75
Effects of some hepatomegalic agents on liver DNA content: relationship to changes in liver blood flow. J Pharm Pharmacol (1983) 0.75
Lack of effect of several barbiturates on liver blood flow. Biochem Pharmacol (1985) 0.75
The effect of urethane and pentobarbital anaesthesia and hepatic portal vein catheterization on liver blood flow in the rat. Experientia (1978) 0.75
Cardiovascular effects of intracerebro-ventricular bradykinin and melittin in the rat. J Pharm Pharmacol (1988) 0.75
Haemodynamic effects of systemic administration of clonidine in the anaesthetized spontaneously hypertensive rat. J Pharm Pharmacol (1979) 0.75